Listen to how Partnerships & Collaborations Have Helped My-Biotics Successfully Create an Expansive Product Pipeline

Time: 4:00 pm
day: Day Two – Track C – 2


  • MyBiotics’ SuperDonor technology – a unique disruptive technology for scalable and standardized artificial FMT
  • MBX-SD-202 – successful completion of Phase I safety with artificial FMT based on the SuperDonor technology
  • MBX-SD-202 – planned clinical development for recurrent C. diff infection